Table 4.
Cost-Effectiveness per Eradication | ∆ Costs (€) | ∆ Effects | ICER | Distribution of Cost-Effectiveness Plane (quadrant, %) | |||
---|---|---|---|---|---|---|---|
NE | NW | SE | SW | ||||
Base case | −6533 | 0.12 | −54,443 | 0 | 1 | 93 | 6 |
Exclusion of outliers | |||||||
Treatment-based | −5926 | 0.08 | −69,730 | 0 | 0 | 91 | 8 |
Cost-based | −7217 | 0.12 | −59,508 | 0 | 0 | 95 | 5 |
Surgical time variance | |||||||
40% shorter | −7416 | 0.12 | −61,799 | 0 | 0 | 92 | 8 |
40% longer | −5651 | 0.12 | −47,087 | 1 | 1 | 92 | 6 |
Hospital stay variance | |||||||
40% shorter | −11477 | 0.12 | −95,642 | 0 | 0 | 93 | 7 |
40% longer | −1589 | 0.12 | −13,244 | 22 | 10 | 66 | 2 |